Shankar K. Nayak - Concepedia

Author

Shankar K. Nayak

Hoag Memorial Hospital Presbyterian ORCID

Also Known As

S K Nayak, S. K. NAYAK, S. K. Nayak, S. Nayak, S.K. Nayak, SHANKAR K. NAYAK, Sankar Priyadarshan Nayak, Shankar K Nayak, Shankar K. Nayak, Shankar Nayak

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Hoag Memorial Hospital Presbyterian Sharp Cabrillo Hospital Rocky Mountain Cancer Centers UCLA Medical Center Campbell Clinic

About

Shankar K. Nayak is an author at Hoag Memorial Hospital Presbyterian specializing in medicine, oncology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	624
2	Cell Biology	6	6	139
3	Cellular Physiology	2	2	40
4	Engineering	1	1	17
5	Natural Sciences	1	1	11

Shankar K. Nayak

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
An Ultrastructural and Histochemical Study of Long-Term Wound Healing after Radial Keratotomy Perry S. Binder, Shankar K. Nayak, Janet K. Deg, American Journal of Ophthalmology Histochemical StudyCutaneous BiologySkin SubstituteScar PreventionWound Care	1987	93
A cell line from an anaplastic transitional cell carcinoma of human urinary bladder Shankar K. Nayak, C O'Toole, Zane Price British Journal of Cancer UrologyTumoral PathologyGenitourinary CancerMedicineSurgical Pathology	1977	79
The growth of endothelium from human corneal rims in tissue culture. Shankar K. Nayak, Perry S. Binder PubMed Regenerative MedicineCorneal-scleral RimsOphthalmologyCorneal DystrophyOcular Tissue	1984	75
Establishing In Vitro Cultures of Autologous Tumor Cells for Use in Active Specific Immunotherapy Robert O. Dillman, Shankar K. Nayak, Linda D. Beutel Journal of Immunotherapy	1993	66
A cell line (SCaBER) derived from squamous cell carcinoma of the human urinary bladder Carol O’Toole, Shankar K. Nayak, Zane Price, International Journal of Cancer	1976	64
Interferon-Gamma or Granulocyte-Macrophage Colony-Stimulating Factor Administered as Adjuvants With a Vaccine of Irradiated Autologous Tumor Cells From Short-Term Cell Line Cultures: A Randomized Phase 2 Trial of the Cancer Biotherapy Research Group Robert O. Dillman, Michael C. Wiemann, Shankar K. Nayak, Journal of Immunotherapy Short-term Cell LineImmunologyImmunoeditingPathologyImmunotherapy	2003	58
The effect of epinephrine and benzalkonium chloride on culture corneal endothelial and trabecular meshwork cells John R. Samples, Perry S. Binder, Shankar K. Nayak Experimental Eye Research OphthalmologyCorneal DystrophyMedicineCulture CornealTrabecular Meshwork Cells	1989	56
Irradiated Cells from Autologous Tumor Cell Lines as Patient-Specific Vaccine Therapy in 125 Patients with Metastatic Cancer: Induction of Delayed-Type Hypersensitivity to Autologous Tumor is Associated with Improved Survival Robert O. Dillman, Linda D. Beutel, Neil M. Barth, Cancer Biotherapy and Radiopharmaceuticals	2002	46
Phase I/II Trial of Autologous Tumor Cell Line–Derived Vaccines for Recurrent or Metastatic Sarcomas Robert O. Dillman, Neil M. Barth, Senthamil R. Selvan, Cancer Biotherapy and Radiopharmaceuticals	2004	37
Patient-Specific Vaccines Derived from Autologous Tumor Cell Lines as Active Specific Immunotherapy: Results of Exploratory Phase I/II Trials in Patients with Metastatic Melanoma Robert O. Dillman, Carol DePriest, Cristina DeLeon, Cancer Biotherapy and Radiopharmaceuticals Tumor Response RateImmunologyImmunoeditingImmune Cell TherapyImmunotherapy	2007	35

Page 1